Coxiella burnetii is an obligate intracellular bacterium and the etiological agent of the zoonotic disease Q fever. Acute human Q fever is characterized by flu-like symptoms that, in some cases, can result in a persistent infection that may reactivate months or years after initial exposure. Mechanisms by which this obligate parasite evades clearance by the host immune response during persistent infection are unknown. Here, we characterized the interaction of C. burnetii with dendritic cells (DC), critical components of both innate and adaptive immunity. Human DC were infected with two isogenic C. burnetii strains that differ in LPS length. Infection by the Nine Mile phase I (NMI) strain, which is fully virulent and produces full-length LPS, did not result in DC maturation. In contrast, infection by the avirulent Nine Mile phase II strain, producing a severely truncated LPS, resulted in toll-like receptor 4-independent DC maturation and Ϸ10-fold more IL-12 and TNF production. NMI did not actively inhibit DC maturation as NMI-infected DC subsequently matured if treated with Escherichia coli LPS or Nine Mile phase II. Furthermore, removal of LPS from NMI dramatically increased its ability to stimulate DC. We propose a model whereby LPS of virulent C. burnetii masks toll-like receptor ligands from innate immune recognition by DC, thereby allowing replication without significant maturation or inflammatory cytokine production. This immune evasion strategy may allow C. burnetii to persist in an immunocompetent host.
T
he obligate intracellular, Gram-negative bacterial pathogen Coxiella burnetii infects a wide range of vertebrate hosts. Acute infection of humans, termed Q fever, results in nonspecific, flu-like symptoms such as high-grade fever and severe preorbital headache. C. burnetii can also establish a persistent infection that may later reactivate and result in chronic endocarditis or hepatitis (1) . Human infection usually occurs via the aerosol route and is most commonly associated with exposure to infected livestock or their products (1) . Additionally, C. burnetii has an extremely low infectious dose (Ͻ10 organisms) (2) and is very stable in the environment, which has led to its designation as a potential bioterrorism agent by the U.S. Centers for Disease Control and Prevention.
The obligate intracellular nature of C. burnetii's lifestyle has precluded the establishment of a system to genetically study the virulence of this organism. C. burnetii strains of decreased or no virulence in animal models have been generated through serial in vitro passage. These isogenic strains have undergone a ''phase variation'' event in which a chromosomal mutation affecting LPS biosynthesis has occurred (3) . Avirulent or ''phase II'' bacteria, typified by the Nine Mile phase II (NMII) strain, produce an LPS that lacks the unique branched terminal sugar-containing O-polysaccharide chain that is characteristic of the LPS of virulent or ''phase I'' organisms, such as the Nine Mile phase I (NMI) strain (4) . Phenotypically, NMI differs from NMII C. burnetii in that only NMI causes disease and persists in a guinea pig model of infection (2) . Moreover, NMI is more resistant than NMII to complement-mediated serum killing (5) . Finally, uptake of NMI by monocytes appears to be mediated by the leukocyte response integrin (␣ v ␤ 3 ), whereas uptake of NMII is mediated by both ␣ v ␤ 3 and complement receptor 3. This behavior has been implicated in differential intracellular trafficking of NMI and NMII (6) .
The acute form of Q fever appears to stimulate an efficient immune response that eventually limits bacterial replication but fails, in many cases, to completely clear the pathogen. Indeed, a recent study by Marmion et al. (7) detected C. burnetii DNA in the bone marrow of 88% of patients 12 years after acute primary Q fever. Persistent, asymptomatic infection of animals by C. burnetii is also well documented (8) . Viable C. burnetii has been recovered from animal tissues up to 500 days postinfection, and latent infection in guinea pigs can be reactivated by pregnancy, irradiation, or corticosteroid treatment (9) (10) (11) .
Peripheral blood lymphocytes (PBLs) from convalescent acute disease patients proliferate in response to C. burnetii antigens (12) . However, PBLs from patients with chronic disease fail to proliferate after exposure to the same antigens, and a suppressor͞regulatory T cell population appears to be involved in this phenomenon (12, 13) . Additionally, cytokine-mediated down-regulation of macrophage function may play a role in C. burnetii persistence (14, 15) . Collectively, these observations indicate the presence of an unknown mechanism of suppression of cell-mediated immunity to C. burnetii.
Activated dendritic cells (DC) express high levels of MHC class II and T cell costimulatory molecules, giving them the unique ability to efficiently stimulate naïve T cells (16, 17) . DC reside in the peripheral epithelial tissues in an immature state (iDC) where they serve as sentinels against invading microorganisms (18) . Contact with a pathogen typically results in stimulation of pattern recognition receptors such as the toll-like receptor (TLR) and subsequent conversion of iDC into mature DC. DC maturation is marked by a reduction in phagocytic ability, an increase in surface expression of MHC class II and costimulatory molecules, and changes in chemokine receptor expression resulting in DC migration to the local lymph nodes (16, 19, 20) .
The attributes of DC place them at the interface of innate and adaptive immunity. Consequently, pathogens have developed a variety of mechanisms to modify DC function as a means of influencing the host immune response in their favor (21) (22) (23) (24) (25) . To determine whether infection by C. burnetii alters DC function, we characterized the interaction of two strains of C. burnetii, producing full-length or truncated LPS, with human monocytederived DC.
Materials and Methods C. burnetii and Reagents. C. burnetii NMI (RSA493) and NMII (RSA439) strains were propagated in Vero cells. Organisms were purified from infected cells by Renografin density gradient centrifugation (26) . Purified bacteria were suspended in K-36 buffer (0.1 M KCl͞0.015 M NaCl͞0.05 M K 2 HPO 4 ͞0.05 M KH 2 PO 4 , pH 7.0). Trichloroacetic acid (TCA) extraction of LPS was performed as described (27) . Brief ly, purified NMI or NMII bacteria were suspended in TCA solution (10% TCA in 0.14 M NaCl) at a concentration of 1 mg͞ml for 4 h at 4°C with occasional mixing. Cells were pelleted by centrifugation at 12,000 ϫ g for 10 min, and the extraction was repeated. LPS from Escherichia coli serotype O111:B4 was purchased from Sigma and used at 500 ng͞ml. Anti-CD14 (clone 134620) antibody (R & D Systems) was used in CD14 blocking experiments.
Infection of Monocyte-Derived DC. Human peripheral blood mononuclear cells were isolated from buffy coats by centrifugation through a Ficoll-Paque Plus (Amersham Pharmacia Biotech) density gradient. Cells were enriched for monocytes (CD14 ϩ cells) by using a RossetteSep Monocyte Enrichment Kit (StemCell Technologies, Vancouver). Monocytes were resuspended at 10 6 cells per ml in DC medium [RPMI ϩ Glutamax (Invitrogen), 5% FBS, 15 mM Hepes, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 100 units͞ml penicillin and 100 g͞ml streptomycin] containing IL-4 (10 ng͞ml) and granulocyte-macrophage colony-stimulating factor (10 ng͞ml) (PeproTech, Rocky Hill, NJ) and cultured for 6 days with replacement of half of the medium and addition of fresh cytokines every other day. Nonadherent DC were harvested by centrifugation and suspended in DC medium without antibiotics. The resulting cells were determined to be Ͼ95% CD11c ϩ ͞CD209 ϩ by f low cytometry. For Coxiella infection experiments, DC were replated in 6-well plates at a concentration of 2 ϫ 10 6 per ml in DC medium. Purified C. burnetii was added directly to the culture medium at a multiplicity of infection (MOI) of 10, 20, 100, or 200 depending on the strain and the experiment (see figure legends). Unless otherwise indicated, the inoculum was not removed. At all MOIs tested, Ͼ90% of DC were viable, and Ͼ95% contained at least one bacterium, as determined by annexin V staining and immunofluorescence microsocopy, respectively.
For CD14 blocking experiments, DC were replated in DC medium that contained 5% human AB serum (Sigma) in place of 5% FBS. DC were incubated with CD14 blocking antibody (10 g͞ml) for 30 min before DC stimulation͞infection. DC maturation was measured by flow cytometry (below).
Flow Cytometry. DC were harvested by incubation for 5 min in cold 0.1 M EDTA in PBS, followed by gentle scraping and centrifugation at 500 ϫ g for 5 min at 4°C. The following mAbs were used to characterize DC phenotypes: antiCD83-APC, antiCD86-PE, antiCD209-PerCP-Cy5.5, antiCD80-FITC, anti-CD40-APC, antiCD11c-PE, and antiHLA-DR-PECy7 (BD Pharmingen). Annexin V-FITC (Caltag, Burlingame, CA) was used according to the manufacturer's instructions to determine cell viability. Approximately 5 ϫ 10 5 DC were stained with antibodies in FACS wash (PBS, 2% FBS, 2.5 mM CaCl 2 , and 0.02% NaN 3 ) for 15 min on ice, washed twice with FACS wash, and fixed with 4% paraformaldehyde. Samples were run on a FACS-Calibur flow cytometer (Becton Dickinson) and analyzed with F LOWJO software (TreeStar, Ashland, OR).
Immunoblotting. For each experimental condition, Ϸ2 ϫ 10 6 DC were harvested by centrifugation at 500 ϫ g for 5 min and resuspended in 100 l of cell lysis buffer [1ϫ PBS, 1% Triton X-100, and Complete Protease Inhibitor (Roche Molecular Biochemicals)]. Lysates were centrifuged at 10,000 ϫ g for 10 min and diluted in 5ϫ SDS͞PAGE sample buffer. Samples were boiled for 5 min, and proteins were separated by SDS͞PAGE on a 12% gel. Proteins were transferred to an Immobilon (Millipore) membrane, blocked overnight with 3% BSA in PBS, then probed with rabbit polyclonal anti-phosphoP38 (Cell Signaling Technology, Beverly, MA) and anti-rabbit IgG-horseradish peroxidase (HRP) antibodies. HRP was detected by using Supersignal West Pico Chemiluminescent Substrate (Pierce). The membrane was then incubated for 15 min at 37°C in Restore Western Blot Stripping Buffer (Pierce) and reprobed with rabbit polyclonal anti-totalp38 (Cell Signaling Technology) and antirabbit IgG-HRP antibodies to normalize for sample loading.
Fluorescence Microscopy. LabTekII chambered glass slides (Nunc) were seeded with 2 ϫ 10 5 DC per well in DC medium and incubated overnight. DC were infected with NMI or NMII C. burnetii at MOI of 200 and 20, respectively. Infected cells were fixed with 4% paraformaldehyde in PBS for 20 min, permeabilized with 0.1% Triton X-100 in PBS for 10 min, and blocked with 0.5% BSA in PBS for 30 min. CD63 (LAMP-3) (BD Pharmingen) and C. burnetii were stained by using mouse anti-human CD63 and convalescent guinea pig C. burnetii antiserum, respectively, and anti-mouse IgG-Alexa594 and anti-guinea pig IgGAlexa488 (Molecular Probes). Fluorescent images were obtained by using a Nikon TE-2000 E inverted microscope equipped with a CoolSNAP HQ digital camera (Roper Scientific, Duluth, GA) and METAMORPH software (Universal Imaging, Downingtown, PA). Images were processed with PHOTOSHOP CS software (Adobe Systems, San Jose, CA).
Quantitative PCR. C. burnetii replication during infection of DC was quantified by using TaqMan quantitative PCR of genome equivalents as described (28) . Briefly, DC in suspension were incubated with NMI or NMII C. burnetii for 2 h at room temperature with gentle rocking. Nonadherent bacteria were removed by washing infected DC once with Hanks' balanced salt solution, followed by centrifugation at 200 ϫ g for 5 min. Infected DC were replated in 6-well plates at 2 ϫ 10 6 cells per well. This point was considered 0 h postinfection. DC were harvested by scraping, and bacterial DNA was isolated with an UltraClean microbial DNA isolation kit (MoBio Laboratories, Carlsbad, CA). The primers͞probe set used was designed with PRIMER-EXPRESS software (Applied Biosystems) and is specific for the C. burnetii dotA gene (28) . The forward and reverse primers are GCGCAATACGCTCAATCACA and CCATGGCCCCAAT-TCTCTT, respectively, and the probe sequence is CCG-GAGATACCGGCGGTGGG. Purified plasmid DNA containing the C. burnetii dotA gene was used as template to generate standard curves ranging from 10 3 to 10 8 plasmid copies.
Cytokine Measurement. IL-12p70 and TNF concentrations in culture supernatants were determined by using OptEIA ELISA kits (BD Pharmingen).
Results

Human DC Undergo Maturation in Response to Avirulent, but Not
Virulent, C. burnetii. To determine whether infection by C. burnetii NMI or NMII strains induces DC maturation, immature human monocyte-derived DC were infected for 48 h, then analyzed by flow cytometry for surface expression of the maturation markers CD80, CD83, CD86, CD40, and HLA-DR. Interestingly, only infection by avirulent NMII induced DC maturation (Fig. 1) . Because NMII C. burnetii is internalized Ϸ10-fold more effi-ciently than NMI by a wide variety of cell types (2), we investigated whether uptake efficiencies could explain the differential maturation of DC in response to C. burnetii infection. The DC response (i.e., the lack of maturation) to NMI infection at an MOI of 200 was indistinguishable from infections at an MOI of 20. These data suggest that LPS length is a major determinant of the effects of C. burnetii strains on DC.
Human DC Produce Inflammatory Cytokines in Response to Avirulent, but Not Virulent, C. burnetii. IL-12 production by DC is essential in driving a T helper 1 (Th1) immune response, which is important for clearance of intracellular pathogens. TNF is a multipotent inf lammatory cytokine important for defense against a variety of intracellular pathogens (29) . We therefore determined whether C. burnetii strains could induce IL-12 and TNF production by DC in vitro. Similar to its ability to induce DC maturation, NMII also consistently stimulated at least 10-fold more IL-12 and TNF production than virulent NMI C. burnetii (Fig. 2) . Several pathogens modulate host immune responses by inducing IL-10 production by DC, and IL-10 levels are increased in some chronic Q fever patients (15) . However, we observed no significant IL-10 production by NMI-or NMII-infected DC when compared with mock-infected controls (data not shown).
Infection of DC with NMII C. burnetii Results in Increased p38
MitogenActivated Protein Kinase (MAPK) Phosphorylation. Many bacterial pathogens induce DC maturation via TLR ligation. This ligation results in a cascade of signaling events, including the phosphorylation of cellular p38 MAPK (30) . To determine whether NMII-induced DC maturation might be caused by TLR stimulation, we examined extracts of infected DC by immunoblot to determine the amount of phosphorylated p38 MAPK present. Infection with NMII resulted in a marked increase in phosphop38 (Fig. 3) . In contrast, infection with the virulent NMI strain had no effect on p38 phosphorylation as compared with mockinfected DC. We can conclude that infection with avirulent NMII C. burnetii results in TLR-associated cell signaling events that do not occur during infection with NMI.
C. burnetii Productively Infects Human DC. We next determined whether both virulent and avirulent C. burnetii could productively infect human DC. DC were infected with either NMI or NMII for 48 h, then immunostained for C. burnetii and the lysosomal marker CD63. Fig. 4A shows that both strains formed large, spacious, CD63-positive vacuoles that appear indistinguishable from vacuoles formed in other cell types known to be permissive for C. burnetii growth (31, 32) . Formation of large, spacious vacuoles and the beginning of exponential growth phase of C. burnetii coincide in other cell types (28) . To examine the growth characteristics of NMI and NMII C. burnetii in DC, we used quantitative PCR to measure the increase in C. burnetii genomes over time. Both NMI and NMII replicated in DC with nearly identical growth kinetics (Fig.  4B) . A typical 48-h lag phase was observed, followed by exponential growth that resulted in Ϸ26-and 47-fold increases in NMI and NMII genomes, respectively. These results are comparable to growth rates observed in other cell types (28, 33) .
NMI C. burnetii Does Not Actively Inhibit DC Maturation.
To determine whether the maturation of DC was being actively inhibited by NMI C. burnetii, DC were infected for 18 h with NMI, then stimulated with E. coli LPS, infected with NMII, or mockinfected. The DC were then incubated for an additional 24 h, and their maturation status was determined by measurement of CD86 expression by flow cytometry (Fig. 5) . Infection by NMI did not inhibit DC maturation in response to subsequent LPS treatment or infection with NMII. A similar maturation response was observed when DC were infected simultaneously with NMI and NMII (data not shown). These data indicate that the immature phenotype of DC infected with NMI C. burnetii is caused by a lack of stimulation rather than an active inhibition of maturation by the bacteria.
DC Maturation in Response to NMII C. burnetii Is CD14-Independent.
Because NMI and NMII C. burnetii are known to differ only in LPS length, and LPS from a variety of bacterial pathogens signal through TLR4, we wanted to determine whether TLR4 signaling was involved in the response of DC to NMII. Antibodies are used to block signaling by several TLRs (34) . However, human DC are somewhat unique in that they express TLR4 only on internal membranes, not on the cell surface, which renders them inaccessible to blocking antibody (35) . We therefore took advantage of the fact that soluble CD14 is required by DC for optimal LPS signaling through TLR4, and that this TLR4-CD14 interaction can be blocked in vitro with a specific antibody (36) . Anti-CD14 antibody had no effect on NMII-induced maturation of DC as measured by increased expression of CD86 (Fig. 6 Left) . In contrast, anti-CD14 antibody partially inhibited DC maturation in response to E. coli LPS (Fig. 6 Right) . Thus, maturation of DC in response to NMII C. burnetii appears to be CD14-independent and by default TLR4-independent.
TCA-Extracted NMI C. burnetii Induces DC Maturation. To determine whether C. burnetii LPS is responsible for the differential maturation and activation of DC in response to NMI and NMII, we used a TCA extraction technique to remove LPS from the outer membrane of NMI C. burnetii. TCA is known to extract LPS from enterobacteria, and its ability to extract full-length C. burnetii LPS has been verified (27) . TCA-extracted or unextracted NMI or NMII C. burnetii was added to the DC culture medium, and DC maturation was measured by flow cytometry after 24 h. Interestingly, DC underwent full maturation in response to TCA-extracted NMI bacteria (Fig. 7 Left), indicating that depletion of LPS had converted these organisms to the NMII phenotype. TCA-treated NMII retained its DC stimulatory capacity (Fig. 7 Right) . Because the TCA extraction process kills C. burnetii, we tested the effects of formaldehyde-fixed NMI on DC. These bacteria did not induce maturation, indicating NMI does not need to be viable to avoid stimulating DC (data not shown). These results suggest full-length LPS of virulent C. burnetii prevents maturation of DC.
Discussion
We show here that NMI C. burnetii infects and grows within DC without subsequent maturation or activation of these cells. Remarkably, this organism can reside within DC in large numbers without being detected. Moreover, the lack of DC maturation is not a result of active inhibition of DC stimulation, as observed with other pathogens (21, 24, 37) . DC maturation activates lysosomal proteases required for antigen processing and presentation (38) and increases the expression of costimulatory molecules necessary for the induction of T cell proliferation (16) . We propose that the lack of DC maturation after infection by virulent C. burnetii results in an immune response that lacks the potency required for complete clearance of the organism, thereby allowing for persistence. In contrast to NMI C. burnetii, the avirulent NMII strain is a potent inducer of DC maturation and activation. Thus, infection by NMII likely results in a robust Th1 immune response that efficiently clears the bacteria. This occurrence may partially explain the inability of NMII to persist in vivo (2) . Recent microarray analysis of the genomes of NMI and NMII has confirmed that the only difference between these strains, at the gene-deletion level, is a Ϸ26-kb deletion in NMII that eliminates a number of genes involved in LPS biosynthesis (ref. 3 and P. Beare and R.A.H., unpublished work). It would therefore seem logical to hypothesize that truncated NMII LPS directly stimulates DC, whereas full-length NMI LPS does not. However, we found that TCA extraction of LPS from NMI converted this strain to the NMII phenotype, suggesting that LPS signaling is not directly responsible for the observed strain differences. We propose that NMI LPS actually shields potential TLR ligands, such as lipoproteins, from recognition by their associated receptors. Support for this hypothesis comes from previous studies showing that LPS of NMI inhibits both binding of antibody to C. burnetii outer membrane proteins and complement-mediated lysis of the pathogen (5, 27) .
Maturation of human DC in response to NMII C. burnetii is CD14-independent; therefore, LPS-mediated TLR4 signaling is likely not involved. These data are consistent with the recent findings of Zamboni et al. (39) , who demonstrated that highly purified lipid A from either NMI or NMII C. burnetii does not stimulate murine bone marrow-derived macrophages via TLR4. They suggest lipoproteins͞lipopeptides of C. burnetii NMII stimulate TLR2 to result in macrophage activation, a process that likely occurs during NMII infection of DC as well. TLR2 ligation is reported to result in mature DC that skew toward a Th2 immune response, whereas TLR4 ligation stimulates large amounts of IL-12, a potent inducer of Th1 immunity (40) . Interestingly, our data show that infection of DC by NMII stimulates IL-12p70 production. Thus, it is possible that TLR2 ligation may also induce a robust Th1-type response.
In addition to NMI, we examined the effects of two chronic disease isolates, S and Priscilla, on DC. These three strains all produce full-length, but biochemically distinct, LPS molecules (41-43). However, we observed no difference in the DC stimulatory capacity between NMI, S, and Priscilla strains in terms of DC maturation, IL-12 production, or p38 MAPK phosphorylation (data not shown). These data suggest LPS length is the primary determinant of C. burnetii's DC stimulatory ability, or lack thereof, and that differences in LPS chemotype do not affect this phenomenon.
Several bacterial pathogens manipulate DC as a means of altering or evading host immune responses. Bordetella pertussis produces filamentous hemagglutinin, which stimulates DC to produce IL- 10 (22) . This process results in development of a regulatory T cell response that is thought to facilitate lung colonization. Yersinia sp. uses at least two strategies for downregulating TLR-mediated DC maturation. One strategy uses a protein called LcrV that induces IL-10 secretion by phagocytes, which consequently down-regulates Th1 responses (25) . Another strategy uses type III secretion of YopJ, a protein that inhibits the NF-B pathway (23) . Mycobacterium tuberculosis blocks DC maturation through its interaction with the DC-SIGN molecule (21) . The immune suppression that results from this blockade has been implicated as an important factor in allowing the organism to persist within its host. Production of an LPS molecule by C. burnetii that not only avoids DC TLR ligation, but also masks TLR engagement of other bacterial surface components, adds to the list of microbial strategies for avoiding induction of DC maturation. Interestingly, C. burnetii cannot totally evade the immune response by this mechanism, as acute Q fever is normally resolved in an otherwise healthy host (1). It appears then that the host can establish an immune response that does not require robust DC stimulation. However, C. burnetii can persist in its host for years after resolution of the acute disease (7) . We believe the ability of this organism to go virtually undetected by DC may play a role in the establishment of persistence.
Moderate up-regulation of HLA-DR was observed during NMI infection of DC in the absence of increased expression of the maturation markers CD86, CD80, CD83, and CD40, suggesting NMI antigen may be presented on the surface of these cells. Immature DC can promote immune tolerance to antigens they present through the induction of T cell anergy or proliferation of regulatory T cells (44) . Thus, in vivo infection of DC by virulent C. burnetii may result in tolerance to the organism's antigens. Alternatively, cytokines that are likely present at the site of infection (e.g., TNF, IFN-␣͞␤, or IL-1) could induce DC maturation. However, recent evidence indicates that DC matured by these inflammatory mediators in the absence of TLR ligation are unable to initiate immune responses (45) . Thus, the precise immunological consequences of the lack of DC maturation in response to in vivo infection by virulent C. burnetii remain to be defined.
The importance of DC in bridging the gap between innate and adaptive immunity is well documented (16) . We present here a description of the effects of C. burnetii infection on DC. Taken together, our results show that the long, branched terminal LPS sugars of C. burnetii may allow the organism to avoid full activation of the adaptive immune response. This proposed ''shielding'' of bacterial TLR ligands by LPS represents a unique immune evasion strategy.
